July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. The system’s high degree of mechanical flexibility also makes it suitable for many surgical procedures.
The ARTIS icono ceiling combines design flexibility with advanced positioning accuracy and intelligent workflows. The new rotational capabilities and simplified cabling of its C-arm permit cone beam CT data acquisitions in just 2.5 seconds at the patient’s head and 4 seconds at the left and right sides of the body. This extremely short 3D spin time reduces motion artifacts and requires less contrast media. Predefined Case Flows settings enable precise intraoperative guidance and excellent clinical outcomes with minimal user interaction, faster system positioning, and reduced patient radiation dose. In this manner, Case Flows help drive standardization and consistency across a healthcare organization. Tools such as Embolization Guidance and myNeedle Companion help simplify the navigation of complex procedures.
The OPTIQ image chain allows the user to reduce patient dose while maintaining consistent image quality. After the user determines the desired image quality, OPTIQ sets the exposure parameters to meet these criteria. Also, the ARTIS icono ceiling can instantly acquire and display images live without any loss in quality.
The system was designed to enhance the customer experience. Its open architectural design allows vendor-neutral third-party integration so the healthcare provider can maintain an up-to-date system, regardless of vendor.
“With the ARTIS icono ceiling, Siemens Healthineers combines excellent image quality and a previously unseen level of design flexibility to be the angiography system of choice for an unprecedented number of interventional radiology and cardiovascular procedures,” said Kris McVey, Vice President of Interventional Radiology and Cardiology at Siemens Healthineers North America.
For more information: www.siemens-healthineers.com
March 20, 2023 
![A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients](/sites/default/files/styles/feed_medium/public/Screen%20Shot%202023-03-16%20at%201.46.39%20PM.png?itok=a2-uUeQz)
